Literature DB >> 9323480

Septicemia due to susceptible Enterococcus faecalis despite prophylaxis with trimethoprim-sulfamethoxazole.

H A Elsner, W Krüger, R Laufs, D Mack.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323480     DOI: 10.1007/BF02447931

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  11 in total

Review 1.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 2.  Coagulase-negative staphylococci: pathogens associated with medical progress.

Authors:  M E Rupp; G L Archer
Journal:  Clin Infect Dis       Date:  1994-08       Impact factor: 9.079

3.  Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media.

Authors:  A E Koch; J J Burchall
Journal:  Appl Microbiol       Date:  1971-11

4.  Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci.

Authors:  A Najjar; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

5.  Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis.

Authors:  C E Chenoweth; K A Robinson; D R Schaberg
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

6.  Sulfonamide and trimethoprim concentrations in human serum and skin blister fluid.

Authors:  J N Bruun; N Ostby; J E Bredesen; P Kierulf; P K Lunde
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

7.  Reversal of activity of trimethoprim against gram-positive cocci by thymidine, thymine and 'folates'.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

8.  Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.

Authors:  S R Crider; S D Colby
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

9.  In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.

Authors:  G L Goodhart
Journal:  JAMA       Date:  1984-11-16       Impact factor: 56.272

10.  Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid.

Authors:  M J Zervos; D R Schaberg
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.